{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:03:24Z","timestamp":1777003404837,"version":"3.51.4"},"reference-count":36,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"PT national funds (FCT\/MCTES, Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia and Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior)","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"Porto Comprehensive Cancer Center Raquel Seruca","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]},{"name":"European Regional Development Fund","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"European Regional Development Fund","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"European Regional Development Fund","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"European Regional Development Fund","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"European Regional Development Fund","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"European Regional Development Fund","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"European Regional Development Fund","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"European Regional Development Fund","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"European Regional Development Fund","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"European Regional Development Fund","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"European Regional Development Fund","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"European Regional Development Fund","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]},{"name":"European Social Fund","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"European Social Fund","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"European Social Fund","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"European Social Fund","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"European Social Fund","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"European Social Fund","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"European Social Fund","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"European Social Fund","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"European Social Fund","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"European Social Fund","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"European Social Fund","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"European Social Fund","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"Portuguese Oncology Institute of Porto\u2014Research Centre","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Portuguese Foundation for Science and Technology (FCT)","doi-asserted-by":"publisher","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"CI-IPOP","doi-asserted-by":"publisher","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Portuguese League Against Cancer","award":["UIDP\/00776\/2020"],"award-info":[{"award-number":["UIDP\/00776\/2020"]}]},{"name":"Portuguese League Against Cancer","award":["CI-IPOP-29-2017\u20132020"],"award-info":[{"award-number":["CI-IPOP-29-2017\u20132020"]}]},{"name":"Portuguese League Against Cancer","award":["CI-IPOP-58-2017\u20132021"],"award-info":[{"award-number":["CI-IPOP-58-2017\u20132021"]}]},{"name":"Portuguese League Against Cancer","award":["CEECIND\/03186\/2017"],"award-info":[{"award-number":["CEECIND\/03186\/2017"]}]},{"name":"Portuguese League Against Cancer","award":["2022.08311.CEECIND"],"award-info":[{"award-number":["2022.08311.CEECIND"]}]},{"name":"Portuguese League Against Cancer","award":["2020.09384.BD"],"award-info":[{"award-number":["2020.09384.BD"]}]},{"name":"Portuguese League Against Cancer","award":["2020.08708.BD"],"award-info":[{"award-number":["2020.08708.BD"]}]},{"name":"Portuguese League Against Cancer","award":["SFRH\/BD\/142479\/2018"],"award-info":[{"award-number":["SFRH\/BD\/142479\/2018"]}]},{"name":"Portuguese League Against Cancer","award":["SFRH\/BD\/146500\/2019"],"award-info":[{"award-number":["SFRH\/BD\/146500\/2019"]}]},{"name":"Portuguese League Against Cancer","award":["57\/2016\/CP1491\/CT0002"],"award-info":[{"award-number":["57\/2016\/CP1491\/CT0002"]}]},{"name":"Portuguese League Against Cancer","award":["UIDP\/00776\/2020\u20135"],"award-info":[{"award-number":["UIDP\/00776\/2020\u20135"]}]},{"name":"Portuguese League Against Cancer","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Muscle-invasive bladder cancer (MIBC) remains a pressing health concern due to conventional treatment failure and significant molecular heterogeneity, hampering the development of novel targeted therapeutics. In our quest for novel targetable markers, recent glycoproteomics and bioinformatics data have pinpointed (glucose transporter 1) GLUT1 as a potential biomarker due to its increased expression in tumours compared to healthy tissues. This study explores this hypothesis in more detail, with emphasis on GLUT1 glycosylation patterns and cancer specificity. Immunohistochemistry analysis across a diverse set of human bladder tumours representing all disease stages revealed increasing GLUT1 expression with lesion severity, extending to metastasis, while remaining undetectable in healthy urothelium. In line with this, GLUT1 emerged as a marker of reduced overall survival. Revisiting nanoLC-EThcD-MS\/MS data targeting immature O-glycosylation on muscle-invasive tumours identified GLUT1 as a carrier of short glycosylation associated with invasive disease. Precise glycosite mapping uncovered significant heterogeneity between patient samples, but also common glycopatterns that could provide the molecular basis for targeted solutions. Immature O-glycosylation conferred cancer specificity to GLUT1, laying the molecular groundwork for enhanced targeted therapeutics in bladder cancer. Future studies should focus on a comprehensive mapping of GLUT1 glycosites for highly specific cancer-targeted therapy development for bladder cancer.<\/jats:p>","DOI":"10.3390\/ijms25063462","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T09:39:31Z","timestamp":1710841171000},"page":"3462","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer"],"prefix":"10.3390","volume":"25","author":[{"given":"Eduardo","family":"Ferreira","sequence":"first","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-0121","authenticated-orcid":false,"given":"Dylan","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"ICBAS\u2014Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal"},{"name":"i3S\u2014Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"INEB\u2014Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-5414","authenticated-orcid":false,"given":"Marta","family":"Relvas-Santos","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"ICBAS\u2014Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal"},{"name":"i3S\u2014Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"INEB\u2014Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal"},{"name":"REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-8719","authenticated-orcid":false,"given":"Rui","family":"Freitas","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"ICBAS\u2014Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal"},{"name":"i3S\u2014Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"INEB\u2014Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-7120","authenticated-orcid":false,"given":"Janine","family":"Soares","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"ICBAS\u2014Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal"}]},{"given":"Rita","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Proteomics Core Facility, MSBio UtechS, 75015 Paris, France"}]},{"given":"Lu\u00eds Pedro","family":"Afonso","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"}]},{"given":"Lu\u00eds","family":"Lima","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"}]},{"given":"Beatriz","family":"Santos","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6311-3990","authenticated-orcid":false,"given":"Martina","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5554-7714","authenticated-orcid":false,"given":"Andr\u00e9 M. N.","family":"Silva","sequence":"additional","affiliation":[{"name":"ICBAS\u2014Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal"},{"name":"REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal"},{"name":"GlycoMatters Biotech, 4500-162 Espinho, Portugal"}]},{"given":"L\u00facio Lara","family":"Santos","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"GlycoMatters Biotech, 4500-162 Espinho, Portugal"},{"name":"Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-0775","authenticated-orcid":false,"given":"Andreia","family":"Peixoto","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"i3S\u2014Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"INEB\u2014Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-6148","authenticated-orcid":false,"given":"Jos\u00e9 Alexandre","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal"},{"name":"RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)\/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal"},{"name":"ICBAS\u2014Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal"},{"name":"GlycoMatters Biotech, 4500-162 Espinho, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Minoli, M., Kiener, M., Thalmann, G.N., Kruithof-de Julio, M., and Seiler, R. (2020). Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165670"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1470-2045(16)30496-X","article-title":"Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): A multicentre, open-label, two-stage, multi-arm, phase 1\/2 trial","volume":"17","author":"Sharma","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wilczak, M., Surman, M., and Przyby\u0142o, M. (2023). Altered Glycosylation in Progression and Management of Bladder Cancer. Molecules, 28.","DOI":"10.3390\/molecules28083436"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molonc.2013.03.001","article-title":"Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours","volume":"7","author":"Ferreira","year":"2013","journal-title":"Mol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Videira, P.A., Correia, M., Malagolini, N., Crespo, H.J., Ligeiro, D., Calais, F.M., Trindade, H., and Dall\u2019Olio, F. (2009). ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-357"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-021-01988-6","article-title":"Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer","volume":"40","author":"Peixoto","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"675.e1","DOI":"10.1016\/j.urolonc.2017.08.012","article-title":"Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases","volume":"35","author":"Lima","year":"2017","journal-title":"Urol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yeagle, P.L. (2016). The Membranes of Cells, Academic Press. [3rd ed.].","DOI":"10.1016\/B978-0-12-800047-2.00005-X"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43356","DOI":"10.18632\/oncotarget.17445","article-title":"The prognostic value of GLUT1 in cancers: A systematic review and meta-analysis","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S822","DOI":"10.1245\/s10434-015-4730-x","article-title":"Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma","volume":"22","author":"Berlth","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1349-7006.2002.tb01214.x","article-title":"Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma","volume":"93","author":"Kang","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E","article-title":"GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis","volume":"83","author":"Haber","year":"1998","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T","article-title":"GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy","volume":"92","author":"Cantuaria","year":"2001","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/sj.bjc.6601260","article-title":"GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: Relationship with vascularity and proliferation as predictors of outcome of ARCON","volume":"89","author":"Hoskin","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1016\/S0021-9258(18)38267-X","article-title":"Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization","volume":"265","author":"Pardridge","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12253-012-9500-5","article-title":"Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/biom2040435","article-title":"Sialyl-tn in cancer: (how) did we miss the target?","volume":"2","author":"Julien","year":"2012","journal-title":"Biomolecules"},{"key":"ref_21","first-page":"162","article-title":"Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases","volume":"27","author":"David","year":"1992","journal-title":"APMIS Suppl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_23","first-page":"393","article-title":"Targeted therapies in the management of metastatic bladder cancer","volume":"1","author":"Fassan","year":"2007","journal-title":"Biologics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.7150\/thno.67409","article-title":"Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion","volume":"12","author":"Gaiteiro","year":"2022","journal-title":"Theranostics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"R110.003251","DOI":"10.1074\/mcp.R110.003251","article-title":"Mass spectrometry based glycoproteomics\u2014From a proteomics perspective","volume":"10","author":"Pan","year":"2011","journal-title":"Mol. Cell. Proteom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"54506","DOI":"10.18632\/oncotarget.17138","article-title":"Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Gu\u00e9rin (BCG) and to oxidative damage","volume":"8","author":"Severino","year":"2017","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molonc.2014.02.008","article-title":"Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells","volume":"8","author":"Carrascal","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13046-022-02438-7","article-title":"Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3\/miR-1-3p axis in bladder cancer","volume":"41","author":"Tan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_29","unstructured":"Andreia, P., Dylan, F., Andreia, M., Marta, R.-S., Rui, F., Tim, S.V., Andreia, B., Eduardo, F., Paula, P., and Marta, C. (bioRxiv, 2023). Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells, bioRxiv, perprint."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1035510","DOI":"10.3389\/fphar.2022.1035510","article-title":"An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors","volume":"13","author":"Temre","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cotton, S., Ferreira, D., Soares, J., Peixoto, A., Relvas-Santos, M., Azevedo, R., Piairo, P., Di\u00e9guez, L., Palmeira, C., and Lima, L. (2021). Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041664"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/0008-5472.CAN-03-2435","article-title":"Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors","volume":"64","author":"Klinger","year":"2004","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1073\/pnas.1608069113","article-title":"Precision glycocalyx editing as a strategy for cancer immunotherapy","volume":"113","author":"Xiao","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1111\/febs.15909","article-title":"Recent advances on smart glycoconjugate vaccines in infections and cancer","volume":"289","author":"Anderluh","year":"2022","journal-title":"FEBS J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bmc.2016.01.044","article-title":"Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein","volume":"24","author":"Cai","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actbio.2023.08.014","article-title":"Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer","volume":"170","author":"Diniz","year":"2023","journal-title":"Acta Biomater."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3462\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:16:02Z","timestamp":1760105762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/6\/3462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijms25063462"],"URL":"https:\/\/doi.org\/10.3390\/ijms25063462","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]}}}